OS
OS Therapies approves amended and restated incentive plan
OS Therapies Inc. filed an Amended and Restated 2023 Incentive Compensation Plan with the SEC, outlining terms for stock-based awards to employees and executives.
Latest 2 stories · newest Sep 9, 2026
OS Therapies Inc. filed an Amended and Restated 2023 Incentive Compensation Plan with the SEC, outlining terms for stock-based awards to employees and executives.
OS Therapies issued a $2.19 million convertible promissory note due September 1, 2026, linked to an automatic conversion upon a $10 million private offering; funds will settle a lawsuit with the Leonite Fund.
The same OS feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/OS/newsSTART FREE